Lumican转基因小鼠角膜SLRP基因差异表达
该实验研究以10只人突变Lumican转基因小鼠和10只野生型C57BL/6J小鼠为对象,于8周龄取角膜行实时荧光定量PCR检测。结果显示Lumican mRNA表达升高、Decorin、Biglycan、Keratocan mRNA表达降低,Fibromodulin无统计学差异;提示cDNA 569T>C突变可能改变Lumican结构与调控SLRP表达的功能。
要点
- 转基因小鼠角膜Lumican mRNA为对照组的1.497倍,差异有统计学意义。
- Keratocan、Decorin、Biglycan mRNA分别降至对照组的0.323、0.648、0.522倍。
- Fibromodulin mRNA为对照组的1.193倍,差异无统计学意义。
核心结论
- 人突变Lumican转基因小鼠角膜组织SLRP成员mRNA表达发生改变,提示Lumican基因突变(cDNA 569T>C)可能破坏其结构并损害调控其他SLRP表达的功能。
- L199P氨基酸改变可能阻碍Lumican与胶原蛋白结合,进而影响SLRP成员表达。
研究设计与样本
- 实验研究,实验组为10只人突变Lumican转基因小鼠(雌雄各5只),对照组为10只同周龄野生型C57BL/6J小鼠(雌雄各5只)。
- 8周龄处死小鼠摘取双侧眼球获得角膜组织,采用实时荧光定量聚合酶链式反应(RT-Q-PCR)检测mRNA表达,两组差异用两独立样本均数t检验并以倍数变化法表示。
主要发现
- Lumican mRNA在转基因小鼠升高至对照组的1.497倍(t=4.34,P<0.05)。
- Keratocan mRNA降低至对照组的0.323倍(t=-95.94,P<0.05),Decorin为0.648倍(t=-9.98,P<0.05),Biglycan为0.522倍(t=-7.74,P<0.05)。
- Fibromodulin mRNA升高至对照组的1.193倍,差异无统计学意义(t=1.66,P>0.05)。
关键数值与推荐
- 转基因小鼠Lumican基因突变位点为cDNA 569T>C,使第199位氨基酸由亮氨酸突变为脯氨酸(L199P)。
- 检测基因包括Lumican、Decorin、Biglycan、Keratocan、Fibromodulin,均比较mRNA水平。
临床怎么用
- 为理解Lumican突变相关角膜基质发育与SLRP调控异常提供分子层面线索。
- 提示Lumican突变可能通过影响与胶原结合而改变角膜细胞外基质相关基因表达。
局限性
- 原文未报告除性别、周龄外的其他纳入条件与样本量估算依据。
- 仅检测mRNA水平,未报告蛋白水平、角膜表型或功能学验证结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To investigate the differential expression of small leucine-rich proteoglycans at mRNA level in Lumican transgenic mouse cornea with Real-time Quantitative PCR Detecting System. Methods: Experimental research. Ten Lumican transgenic mice (5 male and 5 female) were chosen as experimental group and 10 wild mice (5 male and 5 female) were chosen as control group. All the mice were killed and enucleated both eyes at eight weeks of age. Gene expression levels of Lumican, Decorin, Biglycan, Keratocan, Fibromodulin in the excised corneas were analyzed by real-time quantitative polymerase chain reaction (RT-Q-PCR) using Real-time Quantitative PCR Detecting System. Differential expression within each group were analysed by fold changes and independent t-test. Results: There were statistic different expression level of Lumican, Decorin, Biglycan and Keratocan mRNA between experimental and control group. The expression level of Lumican RNA was found to be 1.497-fold increased relative to the control (t=4.34, P<0.05) , while Decorin, Biglycan, Keratocan were 0.648-fold (t=-9.98, P<0.05) , 0.522-fold (t=-7.74,P<0.05), 0.323-fold (t=-95.94, P<0.05)decreased in transgenic mice. Fibromodulin mRNA up regulated 1.193-fold in transgenic mice without statistic difference (t=1.66, P>0.05). Conclusions: Lumican gene mutation(cDNA 569T>C) results in abnormal SLRP expression in transgenic mouse cornea at mRNA level, which may indicate that this mutation changes the structure of Lumican and impairs the function of regulating SLRP expression. Also, Lumican gene mutation leads to amio acid exchanging(L199P), which may hinder Lumican from binding to collagens and result in abnormal expression of SLRP at mRNA level. (Chin J Ophthalmol, 2018, 54:911-917). 目的: 探讨人突变Lumican转基因小鼠角膜组织中小分子亮氨酸蛋白聚糖(SLRP)成员mRNA水平表达变化。 方法: 实验研究。选取10只(雌雄各5只)人突变Lumican转基因小鼠作为实验组,选取10只(雌雄各5只)同周龄野生型C57BL/6J小鼠作为对照组。转基因小鼠Lumican基因突变位点为cDNA 569T>C,使第199位氨基酸由亮氨酸突变为脯氨酸(L99P)。8周龄时脱颈法处死入组小鼠,摘取双侧眼球后获得双眼角膜组织,采用实时荧光定量聚合酶链式反应(RT-Q-PCR)技术分别检测两组小鼠角膜组织中Lumican、Decorin、Biglycan、Keratocan、Fibromodulin基因在mRNA水平的表达。采用两独立样本均数t检验对两组小鼠基因表达差异进行统计学分析,差异以倍数变化法表示。 结果: 实验组转基因小鼠角膜组织中Lumican基因mRNA表达升高,是对照组野生型小鼠的1.497倍,差异具有统计学意义(t=4.34,P<0.05)。实验组小鼠角膜组织中Keratocan基因mRNA表达降低,是对照组的0.323倍,差异具有统计学意义(t=-95.94,P<0.05)。实验组中Decorin基因mRNA表达降低,是对照组的0.648倍,差异均具有统计学意义(t=-9.98,P<0.05)。实验组较对照组Biglycan基因mRNA表达降低,是对照组的0.522倍(t=-7.74,P<0.05),Fibromodulin基因mRNA表达升高,是对照组的1.193倍,差异无统计学意义(t=1.66,P>0.05)。 结论: 人突变Lumican转基因小鼠与野生小鼠相比,角膜组织中SLRP成员mRNA水平表达发生改变,提示Lumican基因突变(cDNA 569T>C)可能导致该基因结构破坏,调控角膜组织中其他SLRP成员基因表达的功能受损。此外,该基因位点的突变导致Lumican核心蛋白中第199位氨基酸由亮氨酸突变为脯氨酸(L199P),提示Lumican基因突变可能阻碍了Lumican与胶原蛋白分子结合,进而影响了SLRP成员的表达。(中华眼科杂志,2018,54:911-917).
引用
- Lai LB, Song YZ, Zhang FJ, et al. [Differential expression of small leucine-rich proteoglycans gene in Lumican transgenic mouse cornea]. Zhonghua Yan Ke Za Zhi. 2018. PMID: 30526790. doi:10.3760/cma.j.issn.0412-4081.2018.12.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。